TABLE 3.
Complication of treatment and patient satisfaction among the studied patients
| VARIABLE | RIGHT SIDE (ID BTX-A) (N=42) |
LEFT SIDE (MN+BTX-A) (N=42) |
TEST | P | ||
|---|---|---|---|---|---|---|
| NO | % | NO | % | |||
| Complication | ||||||
| Pain | 42 | 100 | 14 | 33.3 | χ2 | <0.001** |
| Transient eythema and edema | 20 | 47.6 | 42 | 100 | 42 | |
| Pain degree | ||||||
| Mean± SD | 4.89±2.2 | 1.88±1.1 | t=6.32 | <0.001** | ||
| Satisfaction | ||||||
| Very satisfied | 25 | 59.5 | 34 | 81 | χ2 4.61 |
0.03* |
| Satisfied | 17 | 40.5 | 8 | 19 | ||
| Slightly satisfied | 0 | 0 | 0 | 0 | ||
| Not satisfied | 0 | 0 | 0 | 0 | ||
Id BTX-A: intradermal injection of botulinum toxin type A; Mn+BTX-A : microneedling + botulinum toxin type A; χ2: Chi square test; SD: Standard deviation; t:independent t test; *:Significant (p<0.05); **: Highly significant (P<0.001)